OreStocks

MustGrow Biologics Corp. press release

MustGrow Biologics Corp. (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0) Obtains Patent for Mustard-Derived Fumigation of Stored Vegetables, Grains

TSXV - TSX Venture Exchange · Canada

Alternatives to potato sprout inhibition in critical need as U.S. moves towards eliminating CIPC CIPC, leading agrochemical product used for sprout suppression, was banned by EU in October MGRO’s patent focused on controlling vegetable, potato sprouting without harmful synthetic chemicals

MustGrow Biologics (CSE: MGRO) (OTCQB: MGROF) (FRA: 0C0)has been granted an exclusive patent licensing from the University of Idaho in Moscow, Idaho (https://ibn.fm/vW2Ag). The patent is in connection with a natural biopesticide mustard-based treatment of stored produce and other foods. The ability the treatment may have for sprout suppression of potatoes is gaining particular interest in Idaho, which is the largest producer of potatoes in the country.

“Alternatives to potato sprout inhibition are in critical need as the U.S. moves towards eliminating CIPC,” said MustGrow’s recently appointed scientific advisor, Dr. Matthew J. Morra, a leading world expert on value-added products derived from...

Read more »

NOTE TO INVESTORS: The latest news and updates relating to MGROF are available in the company’s newsroom at http://ibn.fm/MGROF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Wordson all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brandsthat make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW) 8033 Sunset Blvd Suite 1037-IW Los Angeles, CA 90046 310.299.1717 Office www.InvestorWire.com Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Earlier from MustGrow Biologics Corp.